Loading...
4DMedical Limited
4DX.AX•ASX
HealthcareMedical - Devices
$0.29
$0.005(1.75%)
4DMedical Limited (4DX.AX) Stock Overview
Explore 4DMedical Limited’s financial performance, market position, analyst ratings, and future outlook.
Revenue Growth
1230.44%
↑ 1230.44%
Profit Growth
$-0.06
↓ 14.36%
EPS Growth
$-0.06
↓ 10.00%
Operating Margin
-468.82%
↑ 10.16%
ROE
-60.46%
↓ 14.36%
Dividend Yield
0.00%
Analyst Recommendations data is not available for 4DX.AXAnalyst Recommendations details for 4DX.AX are currently unavailable. We're actively monitoring for updates and will publish them as soon as they’re released. Please check back again shortly.
Company Profile
4DMedical Limited operates as a medical technology company in Australia and the United States. It commercializes XV Technology, a four-dimensional lung imaging technology. The company also offers software as a service delivery model; XV lung ventilation analysis software; Permetium, a preclinical imaging system which quantify regional changes in pulmonary function; and AccuVent 200, a small animal ventilator. The company was incorporated in 2012 and is based in Carlton, Australia.
CEO
Dr. Andreas Fouras M.A.I.C.D., Ph.D.
Employees
145
Headquarters
Melbourne Connect, Carlton, VIC
Founded
2020